POSC will be #1 Stock of the Year
1. Covidien sold their radiopharmacies – COV total annual revenues from this business was approximately $180 Million (US only). COV did this to get into a better business model, obtaining more revenues and bigger profits from this business area. COV has the resources to move this forward quickly, today, before any other competitors get their act together. The sales will begin this Quarter, not next year, which will make positive earnings for POSC.
2. POSC now has multiple business facilities to ramp up production. Positron obtained approval to warehouse radioactive materials & move their business model toward a 'service-oriented' business plan to provide ongoing revenue streams through distribution of radiopharmacy supplies using the Pharm Assist (PA).
3. Now POSC has announced exclusive rights from COV to distribute COV’s product(s).
4. Since POSC can customize their PA with COV, POSC can also customize their PA and partner with COV’s competitors. COV’s reach represents only approximately 2,000 of the 7,000 potential business opportunities. Each successful opportunity will provide a continuing revenue stream from selling / distributing drugs.
5. All competitors will see the same opportunity to place a radiopharmacy in every hospital/ group facilities to make traditional radiopharmacies obsolete in the US and around the world (GLOBALLY). COV and POSC are joined together as both will benefit.
6. POSC’s new proprietary automated radiopharmaceutical device is used in both the cardiac and oncology sectors (a huge multi-billion dollar market). If COV sees the potential business, how long will it be before POSC is approached by other COV’s competitors both in US and globally? Rumors persist that they are now in discussions with other major companies.
7. COV would not be working with POSC unless they thought it would be profitable. POSC will no longer be viewed as a minor player in this business area.
8. As COV sells these PAs around the globe, POSC’s Attrius PET Scanners will also be presented to the same hospital/ group facilities and this will add to the sales opportunities of both POSC and COV. Again, huge multi-billion dollar markets.
9. Once COV understands the full potential, POSC will be seen as major component of COV’s revenue stream. To protect and enhance their revenues, how long will COV wait before POSC is acquired and becomes part of COV?
I expect that POSC will move up very nicely after COV states that their deal with POSC is "material"! - My guess is within one month - possibly on September 15th.
POSC must have staff at these facilities already in place producing systems. They are bring additional staff (hiring) as it is need for expansion NOW.
Go POSC!
AI
